Back
PepsiCo Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
56
PEP
PepsiCo
Last Price:
$149.00
Seasonality Move:
6.58%
Sell
16
CRSP
CRISPR Therapeutics AG
Last Price:
$40.99
Seasonality Move:
6.36%
Sell
16
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $40.97. The Score for CRSP is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $40.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight selling pressure.
PEP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 50.86 | Buy |
Chaikin Money Flow: | 4015785 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 42.36 | Sell |
Chaikin Money Flow: | -962611 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.7 - 47.9) | Sell |
Bollinger Bands (100): | (40.86 - 49.46) | Sell |
PEP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 151.46 | Sell |
20-day SMA: | 150.79 | Buy |
50-day SMA: | 148.9 | Buy |
200-day SMA: | 163.39 | Sell |
8-day EMA: | 150.84 | Buy |
20-day EMA: | 150.72 | Buy |
50-day EMA: | 151.26 | Buy |
200-day EMA: | 160.49 | Sell |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.83 | Sell |
20-day SMA: | 45.1 | Sell |
50-day SMA: | 42.74 | Sell |
200-day SMA: | 48.59 | Sell |
8-day EMA: | 42.61 | Sell |
20-day EMA: | 43.39 | Sell |
50-day EMA: | 43.71 | Sell |
200-day EMA: | 48.24 | Sell |
PepsiCo Earnings Growth & PEP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.80 per share, an increase this year of $0.14 per share, and an increase next year of $0.53 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.06 per share, an increase this year of $0.22 per share, and an increase next year of $0.93 per share.
PepsiCo Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |